NCT05839678

Brief Summary

Multicenter trial about anterior mediastinal cysts

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
19mo left

Started Dec 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress69%
Dec 2022Dec 2027

Study Start

First participant enrolled

December 1, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 20, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 3, 2023

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

November 20, 2024

Status Verified

November 1, 2024

Enrollment Period

5 years

First QC Date

April 20, 2023

Last Update Submit

November 18, 2024

Conditions

Cysts

Outcome Measures

Primary Outcomes (1)

  • Percentage correctly diagnosed cystic laesions

    2000-2022

Secondary Outcomes (1)

  • Patient characteristics, complications, comborbidities

    2000-2022

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with cysts in the anterior mediastinum

You may qualify if:

  • Thymic cysts
  • Bronchogenic cysts
  • Pericardial cysts
  • Cystic thymoma
  • Cystic teratoma

You may not qualify if:

  • Patients \<18 years old
  • Patients without radiological imaging
  • Patients without approval for follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maastricht UMC

Maastricht, Limburg, Netherlands

RECRUITING

MeSH Terms

Conditions

Cysts

Condition Hierarchy (Ancestors)

NeoplasmsPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator, MD PhD

Study Record Dates

First Submitted

April 20, 2023

First Posted

May 3, 2023

Study Start

December 1, 2022

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

November 20, 2024

Record last verified: 2024-11

Locations

NL(1)